+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Disease prediction using graph convolutional networks: Application to Autism Spectrum Disorder and Alzheimer's disease



Disease prediction using graph convolutional networks: Application to Autism Spectrum Disorder and Alzheimer's disease



Medical Image Analysis 48: 117-130



Graphs are widely used as a natural framework that captures interactions between individual elements represented as nodes in a graph. In medical applications, specifically, nodes can represent individuals within a potentially large population (patients or healthy controls) accompanied by a set of features, while the graph edges incorporate associations between subjects in an intuitive manner. This representation allows to incorporate the wealth of imaging and non-imaging information as well as individual subject features simultaneously in disease classification tasks. Previous graph-based approaches for supervised or unsupervised learning in the context of disease prediction solely focus on pairwise similarities between subjects, disregarding individual characteristics and features, or rather rely on subject-specific imaging feature vectors and fail to model interactions between them. In this paper, we present a thorough evaluation of a generic framework that leverages both imaging and non-imaging information and can be used for brain analysis in large populations. This framework exploits Graph Convolutional Networks (GCNs) and involves representing populations as a sparse graph, where its nodes are associated with imaging-based feature vectors, while phenotypic information is integrated as edge weights. The extensive evaluation explores the effect of each individual component of this framework on disease prediction performance and further compares it to different baselines. The framework performance is tested on two large datasets with diverse underlying data, ABIDE and ADNI, for the prediction of Autism Spectrum Disorder and conversion to Alzheimer's disease, respectively. Our analysis shows that our novel framework can improve over state-of-the-art results on both databases, with 70.4% classification accuracy for ABIDE and 80.0% for ADNI.

(PDF emailed within 0-6 h: $19.90)

Accession: 058427331

Download citation: RISBibTeXText

PMID: 29890408

DOI: 10.1016/j.media.2018.06.001


Related references

Convolutional Neural Networks-Based MRI Image Analysis for the Alzheimer's Disease Prediction From Mild Cognitive Impairment. Frontiers in Neuroscience 12: 777, 2018

Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder. Invertebrate Neuroscience 11(2): 73-83, 2012

Multiparametric MRI characterization and prediction in autism spectrum disorder using graph theory and machine learning. Plos One 9(6): E90405, 2015

Hyperplasticity in Autism Spectrum Disorder confers protection from Alzheimer's disease. Medical Hypotheses 83(3): 337-342, 2015

Proteins Commonly Linked to Autism Spectrum Disorder and Alzheimer's Disease. Current Protein and Peptide Science 19(9): 876-880, 2017

The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review. Frontiers in Pediatrics 2: 87, 2014

Natural and Synthetic Neurotoxins in Our Environment: From Alzheimer's Disease (AD) to Autism Spectrum Disorder (ASD). Journal of Alzheimer's Disease and Parkinsonism 6(4), 2016

Graph theoretic analysis of structural connectivity across the spectrum of Alzheimer's disease: The importance of graph creation methods. Neuroimage. Clinical 7: 377-390, 2016

Longitudinal Prediction of Infant Diffusion MRI Data via Graph Convolutional Adversarial Networks. IEEE Transactions on Medical Imaging 2019, 2019

Application of graph theory: prediction of glycogen synthase kinase-3 beta inhibitory activity of thiadiazolidinones as potential drugs for the treatment of Alzheimer's disease. European Journal of Pharmaceutical Sciences 24(2-3): 213-218, 2005

Crystal Graph Convolutional Neural Networks for an Accurate and Interpretable Prediction of Material Properties. Physical Review Letters 120(14): 145301, 2018

Diffuse lewy body disease disease spectrum disorder or variety of alzheimer disease. International Journal of Geriatric Psychiatry 7(4): 229-234, 1992

Visual Explanations From Deep 3D Convolutional Neural Networks for Alzheimer's Disease Classification. AMIA ... Annual Symposium Proceedings. AMIA Symposium 2018: 1571-1580, 2019

Classification of Alzheimer's Disease by Combination of Convolutional and Recurrent Neural Networks Using FDG-PET Images. Frontiers in Neuroinformatics 12: 35, 2018

Multi-Modality Cascaded Convolutional Neural Networks for Alzheimer's Disease Diagnosis. Neuroinformatics 16(3-4): 295-308, 2018